Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 4 » Issue 3

Behavior and neuropsychiatric manifestations in Angelman syndrome

Authors Karine Pelc, Guy Cheron, Bernard Dan

Published 6 June 2008 Volume 2008:4(3) Pages 577—584


Karine Pelc1, Guy Cheron2, Bernard Dan1,2

1Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles (ULB), Brussels, Belgium; 2Laboratory of Neurophysiology and Movement Biomechanics, Université Libre de Bruxelles (ULB), Brussels, Belgium

Abstract: Angelman syndrome has been suggested as a disease model of neurogenetic developmental condition with a specific behavioral phenotype. It is due to lack of expression of the UBE3A gene, an imprinted gene located on chromosome 15q. Here we review the main features of this phenotype, characterized by happy demeanor with prominent smiling, poorly specific laughing and general exuberance, associated with hypermotor behavior, stereotypies, and reduced behavioral adaptive skills despite proactive social contact. All these phenotypic characteristics are currently difficult to quantify and have been subject to some differences in interpretation. For example, prevalence of autistic disorder is still debated. Many of these features may occur in other syndromic or nonsyndromic forms of severe intellectual disability, but their combination, with particularly prominent laughter and smiling may be specific of Angelman syndrome. Management of problematic behaviors is primarily based on behavioral approaches, though psychoactive medication (eg, neuroleptics or antidepressants) may be required.

Keywords: Angelman syndrome, UBE3A, chromosome 15, behavioral phenotypes, autism, neurogenetics

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Two thymus-related autoimmune disorders: a case report and review of the literature

Mirtavoos-Mahyari H, Khosravi A, Esfahani-Monfared Z, Shadmehr MB

OncoTargets and Therapy 2014, 7:633-636

Published Date: 10 May 2014

The relationship between Lin28 and the chemotherapy response of gastric cancer

Teng RY, Zhou JC, Jiang ZN, Xu CY, Li ZD, Wang QC, Xu CP, Guo JF, Shen JG, Wang LB

OncoTargets and Therapy 2013, 6:1341-1345

Published Date: 24 September 2013

Prognostic significance of different immunohistochemical S100A2 protein expression patterns in patients with operable nonsmall cell lung carcinoma

Hountis P, Foukas PG, Matthaios D, Kefala M, Chelis L, Pantelidaki A, Panayiotides IG, Karakitsos P, Kakolyris S

OncoTargets and Therapy 2012, 5:363-373

Published Date: 21 November 2012

Nimodipine-loaded mixed micelles: formulation, compatibility, pharmacokinetics, and vascular irritability study

Song X, Jiang Y, Ren CJ, Sun X, Zhang Q, Gong T, Zhang ZR

International Journal of Nanomedicine 2012, 7:3689-3699

Published Date: 13 July 2012

Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines

Zhu XM, Wang YX, Leung KCF, Lee SF, Zhao F, Wang DW, Lai JMY, Wan C, Cheng CHK, Ahuja AT

International Journal of Nanomedicine 2012, 7:953-964

Published Date: 21 February 2012

Electroencephalographic and behavioral convulsant effects of hydrobromide and hydrochloride salts of bupropion in conscious rodents

David C Henshall, Nick Dürmüller, H Steve White, Robert Williams, et al.

Neuropsychiatric Disease and Treatment 2009, 5:189-206

Published Date: 12 March 2009

Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients

Hisashi Higuchi, Kazuhiro Sato, Shingo Naito, Keizo Yoshida, Hitoshi Takahashi, et al

Neuropsychiatric Disease and Treatment 2009, 5:151-155

Published Date: 26 February 2009

Epidemiology and treatment of post-stroke depression

Stefano Paolucci

Neuropsychiatric Disease and Treatment 2008, 4:145-154

Published Date: 8 February 2008